Airstrikes Hit Houthis in Taiz
According to the article, the American company Pfizer announced the development of a new COVID-19 treatment administered through injection. The aim is to shorten the duration of the illness and reduce the need for hospitalization. The treatment is likely to be effective for high-risk individuals, and it is expected to be available in markets before the end of 2026, with an estimated cost of around $80 per dose. The company is currently conducting clinical trials on this treatment, which have shown its effectiveness in reducing the duration and symptoms of the illness, with the potential to change standards for treating those infected with the virus.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)